Status:
ACTIVE_NOT_RECRUITING
MicroRNA Markers in Head and Neck Cancers
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Squamous Cell Carcinoma of Head and Neck
Eligibility:
All Genders
18-100 years
Brief Summary
The purpose of this study is to investigate the presence of miRNA markers in saliva, blood, FNA and tissue specimens in patients with and without head and neck cancer and evaluate whether these miRNA ...
Detailed Description
Micro RNA (miRNA) markers were initially discovered in 1993 and recent research has shown that they have great potential for use as both surveillance and prognostic markers in cancer treatment, as wel...
Eligibility Criteria
Inclusion
- Subjects between the ages of 18 and 100
- Patients who are seen and evaluated by a provider within the adult ENT clinic at University of Colorado Hospital
- Patients that present with a current or past diagnosis of head and neck cancer -OR-Patients undergoing tonsillectomy or sleep surgery as standard of care (control group)
Exclusion
- Under the age of 18 or over the age of 100
- Unwilling to participate
Key Trial Info
Start Date :
November 16 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2026
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT04305366
Start Date
November 16 2012
End Date
February 1 2026
Last Update
February 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Cancer Center
Aurora, Colorado, United States, 80045